Elite Pharmaceuticals, Inc. (ELTP) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Elite Pharmaceuticals, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
8.67
Strong
WeakModerateStrong
P/B Ratio
3.93
Strong
WeakModerateStrong
Earnings Yield
11.54%
Strong
WeakModerateStrong
Profitability Health
2026Return on Equity
45.38%
Strong
WeakModerateStrong
Operating Margin
33.56%
Strong
WeakModerateStrong
Net Profit Margin
30.14%
Strong
WeakModerateStrong
Growth Indicators
2026Revenue Growth
77.13%
Strong
WeakModerateStrong
Net Income Growth
1140.01%
Strong
WeakModerateStrong
EPS Growth
1145.00%
Strong
WeakModerateStrong
Efficiency & Liquidity
2026Current Ratio
6.45
Strong
WeakModerateStrong
Quick Ratio
-1215.99
Weak
WeakModerateStrong
Asset Turnover
1.08x
Strong
WeakModerateStrong
Inventory Turnover
0.00x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
58.70%
Strong
WeakModerateStrong
EV / Free Cash Flow
-1.29x
Strong
WeakModerateStrong
Net Debt / EBITDA
-573.16x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.137
Strong
WeakModerateStrong
Return on Invested Capital
32.33%
Strong
WeakModerateStrong
Cash Conversion Cycle
103041.71 days
Weak
WeakModerateStrong
Fortress screener guardrails
3/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for ELTP.
View Financial Statements